Registration Number : 301MF10021
Registrant's Address : 6-8, Fructo(´)s Gelabert 08970 Sant Joan Despi(´)(Barcelona) Spain
Initial Date of Registration : 2019-06-25
Latest Date of Registration : 2019-06-25
51
PharmaCompass offers a list of Clozapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clozapine manufacturer or Clozapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clozapine manufacturer or Clozapine supplier.
PharmaCompass also assists you with knowing the Clozapine API Price utilized in the formulation of products. Clozapine API Price is not always fixed or binding as the Clozapine Price is obtained through a variety of data sources. The Clozapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lapenax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lapenax, including repackagers and relabelers. The FDA regulates Lapenax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lapenax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lapenax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lapenax supplier is an individual or a company that provides Lapenax active pharmaceutical ingredient (API) or Lapenax finished formulations upon request. The Lapenax suppliers may include Lapenax API manufacturers, exporters, distributors and traders.
click here to find a list of Lapenax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lapenax Drug Master File in Japan (Lapenax JDMF) empowers Lapenax API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lapenax JDMF during the approval evaluation for pharmaceutical products. At the time of Lapenax JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lapenax suppliers with JDMF on PharmaCompass.
